购物车
全部删除
您的购物车当前为空
别名 PXN (p-Y118), PXN (p-Tyr118), p-PXN (Y118), p-PXN (Tyr118), Phospho-PXN (Y118), Paxillin alpha, Paxillin, PAXI_HUMAN, PAX1, PAX 1, Paired box protein Pax 1, FLJ23042, FLJ16691
Anti-Phospho-PXN (Tyr118) Antibody (8Q852) 是一种抗体,靶向 Phospho-PXN (Tyr118)。Anti-Phospho-PXN (Tyr118) Antibody (8Q852) 可用于 ELISA,WB。
Anti-Phospho-PXN (Tyr118) Antibody (8Q852) 是一种抗体,靶向 Phospho-PXN (Tyr118)。Anti-Phospho-PXN (Tyr118) Antibody (8Q852) 可用于 ELISA,WB。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μL | ¥ 1,315 | 5日内发货 | |
| 100 μL | ¥ 2,195 | 5日内发货 |
| 产品描述 | Anti-Phospho-PXN (Tyr118) Antibody (8Q852) is an antibody targeting Phospho-PXN (Tyr118). Anti-Phospho-PXN (Tyr118) Antibody (8Q852) can be used in ELISA,WB. |
| 别名 | PXN (p-Y118), PXN (p-Tyr118), p-PXN (Y118), p-PXN (Tyr118), Phospho-PXN (Y118), Paxillin alpha, Paxillin, PAXI_HUMAN, PAX1, PAX 1, Paired box protein Pax 1, FLJ23042, FLJ16691 |
| Ig Type | Rabbit IgG |
| 克隆号 | 8Q852 |
| 交叉反应 | Human |
| 验证活性 | Western Blot -Positive WB detected in Hela whole cell lysate,A549 whole cell lysate,HepG2 whole cell lysate(treated with Calyculin A or EGF) -All lanes Phospho-PXN antibody at 1.43μg/ml -Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution -Predicted band size: 68 KDa -Observed band size: 68 KDa |
| 应用 | ELISAWB |
| 推荐剂量 | WB:1:500-1:5000. |
| 抗体种类 | Monoclonal |
| 亚细胞定位 | Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Cytoplasm, cell cortex. |
| 构建方式 | Recombinant Antibody |
| 纯化方式 | Affinity-chromatography |
| 性状 | Liquid |
| 缓冲液 | Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| 研究背景 | Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). |
| 偶联 | Unconjugated |
| 免疫原 | A synthetic peptide: Human Phospho-PXN (Y118) |
| 抗原种属 | Human |
| 基因名称 | PXN |
| 基因ID | |
| Uniprot ID | |
| 研究领域 | Signal Transduction |
| 储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |
评论内容